Niacinamide in Skincare for Brands: Formulation Choices and Claims Evidence

Niacinamide is one of the easier actives to put into a product and one of the harder ones to claim well. It is water-soluble and appears in serums, creams, toners and cleansers. That ease is the trap: brands often pick a percentage they have seen elsewhere, approve a sample on feel, and only later find that the claim on the box has no evidence behind it for their own finished product.

This guide is written for brand owners and product managers who are briefing a manufacturer. It does not repeat what niacinamide is or how it works in skin. For that background, our skincare ingredients guide has a short, evidence-bounded profile. Here the question is narrower: how to decide the format, what to ask for, how to judge samples and what evidence each claim needs.

Decision summary for brands

• Start from the claim and the market, then choose the format. A leave-on serum, a leave-on cream and a rinse-off cleanser give niacinamide very different contact with skin, so they support different claims.
• Do not copy a percentage from a study or a competitor. Ask the manufacturer to propose a level for your formula, state the basis (pure material or supplier solution) and explain why.
• Request raw-material documents per lot: specification, certificate of analysis (COA), identity and assay, and the supplier's limit for residual nicotinic acid.
• Plan finished-product work on your actual formula and pack: stability, microbiological quality and preservation, packaging compatibility, safety assessment, and any efficacy or consumer test your claims need.
• Keep three layers of evidence apart: published ingredient research, data on a similar formula, and data on your final product. Match the evidence to the exact claim and market; testing the final product gives the most direct support.
• In the US, claims to treat or prevent disease, or to affect the structure or function of the skin, make the product a drug, even if it also changes appearance. In the EU, claims need adequate, verifiable evidence relevant to the product and benefit claimed.

Start With a Product Brief, Not a Percentage

A common weak first message to a manufacturer is "We want a 10% niacinamide serum." It fixes a number before anyone has agreed who the product is for, how it should feel, what the pack will say or where it will be sold. A better brief describes the outcome and lets the formulator propose the level and system.

The example below is a hypothetical brief written for this article. It is not a GZ Cosmetics Lab client project, a delivered product or a formula we hold.

Swipe horizontally to view all columns →

The brief does not name a niacinamide percentage, a supplier or a pH. Those are the manufacturer's proposals to make and justify.

Section takeaway: brief the outcome, the claims, the market and the pass criteria. Ask the manufacturer to propose the niacinamide level and explain the basis.

Serum, Cream or Rinse-Off: How the Format Changes the Decision

Format controls how long niacinamide stays on skin and what else sits in the formula with it. A serum and a cream are both leave-on but differ in base, feel and co-actives. A rinse-off product contacts skin briefly and is washed away.

The evidence base differs by format too. One published clinical study on niacinamide appearance benefits, by Bissett and colleagues in 2004, tested a moisturizer with 5% niacinamide against the same moisturizer without it in 50 women aged 40 to 60, over 12 weeks, in a split-face design. That is a leave-on study of one formula in one population. It says nothing directly about a rinse-off product, and it does not set an "effective level" for other formats.

Swipe horizontally to view all columns →

The serum route puts the most attention on the active, so it attracts the strongest claims. If "visibly more even-looking skin" is the headline, plan a test on the finished serum. Serums also tend to carry several actives; our face serum manufacturer guide covers pH windows when actives share a bottle. List every co-active you want so the formulator can say early whether they belong in one product.

The cream route suits brands that lead with comfort or moisture. Niacinamide goes into the water phase of an emulsion, so evaluation focuses on emulsion behavior, texture and how the cream ages, as much as on the active.

The rinse-off route is easy to overclaim. A niacinamide cleanser can be a sound product, but leave-on results do not transfer to a product washed off within a minute. If the pack implies a serum-like benefit, the brand needs evidence on the cleanser itself. Otherwise keep claims to cleansing, after-wash feel and the presence of niacinamide.

Do not ask for one "effective concentration" across the three formats. The level should be proposed per formula, stated on a clear basis and tied to the evidence you plan to collect.

Section takeaway: choose the format by contact time and claim ambition. Leave-on studies inform leave-on products only, and a rinse-off product needs its own evidence for anything beyond cleansing and feel.

Raw-Material Documents to Request

Two products can both list "Niacinamide" and use different suppliers, grades and lots. Documents let buyers check the material difference before evaluating how each formula behaves.

Raw-material specifications are grade-specific. Ask which niacinamide grade is proposed, how its assay and residual nicotinic-acid limit are documented, and what formulation conditions the supplier recommends. Those questions need the actual grade's current technical sheet, not a generic industry number. A supplier sheet does not establish that GZ Cosmetics Lab uses that grade or that a finished product meets a claim.

The right-hand column below is deliberately blunt: nothing in it is a document already issued for your project.

Swipe horizontally to view all columns →

Also ask what happens if the supplier changes. A formula approved with one grade may behave differently with another on color, odor or sensation, so agree in writing that substitutions are notified before use.

Section takeaway: request the specification, the lot COA and the basis of the stated level. Treat supplier literature as a guide to the right questions, not as the specification of your own material.

Finished-Product Checks: What to Plan, What to See

Raw-material documents prove the input, not the product. A grade's behavior in a supplier's test system says little about your serum in your bottle after months on a warm shelf. The checks below are to scope and request with the manufacturer; none should be assumed to exist for a sample you have not received.

Stability. Agree the storage conditions, time points and what is measured: appearance, color, odor, pH, viscosity and, where the claim depends on it, the niacinamide level over time. Look for crystals in high-level serums and separation in creams. Our guide on how to read a stability testing report explains what a useful report should contain.

Microbiological quality and preservation. Water-based niacinamide products need a preservation system that works in the finished formula. Ask for microbial limits at release and a preservative efficacy (challenge) test on the final formula. Our challenge testing guide explains the difference between a screening test and a full study.

Packaging compatibility. The pack is part of the product. Test the formula in the actual bottle, closure and dropper or pump, and check for weight loss, discoloration, leaks and dosing problems. See our article on packaging compatibility testing for pumps, droppers and airless bottles.

Safety assessment. Your target markets decide what safety documentation is required and who prepares it. Plan this before the formula is locked, because a change after assessment can mean repeating work.

Efficacy and consumer testing. Decide which claims need a test and which kind. An instrumental or expert-graded study can support appearance claims such as more even-looking tone. A home-use consumer test can support perception claims such as "felt smoother." Our guides to efficacy testing and consumer testing panels explain how to match a claim to a study.

Keep a simple status per check in your project file: planned, in progress, report received, or not required for our claims. Do not move a claim onto artwork until the supporting evidence has been reviewed for that wording, formula, pack and market. Some claims may need a direct finished-product study; the evidence plan depends on the claim.

Section takeaway: every finished-product check is a separate deliverable. Scope it, track it and do not treat a plan as a result.

Claims Evidence: Three Layers You Should Not Merge

Most niacinamide claim problems come from treating three kinds of evidence as one.

1. Ingredient research. Published studies on niacinamide, such as the 2004 leave-on moisturizer study described above. This shows what a specific formula did under specific conditions. It is useful for choosing the ingredient and setting expectations.
2. Data on a similar or target formula. Results the manufacturer or a supplier holds for a related base, or for an earlier version of your formula. This is closer, but differences in base, level, pack or use can change the result.
3. Data on your final product. Tests on the formula and pack you will actually sell. This is generally the most direct evidence for a claim about your product.

The EU's common criteria for cosmetic claims require adequate, verifiable evidence appropriate to the product and benefit claimed. An ingredient's properties cannot simply be assigned to the finished product; an extrapolation needs supporting evidence, which can include showing that the ingredient is present at an effective concentration. The required evidence depends on the claim, and need not always be a new clinical test of the final product. When a benefit depends on specific conditions, such as use with another product, the claim must make that clear. The EU responsible person must keep claim wording consistent with the supporting product information file.

The US starts from a different place. The FDA's cosmetics labeling guidance states that FDA does not approve cosmetic claims before marketing and has no list of approved claims, but claims must be truthful and not misleading. It also states that a product marketed with claims to treat or prevent disease, or to affect the structure or function of the body, including the skin, is a drug under the law, even if it also affects appearance. Advertising claims fall under the Federal Trade Commission. For a wider comparison across markets, see our guide on what turns a cosmetic into a drug.

The table shows how wording moves a claim between categories. Treat it as a starting point for review with your regulatory adviser, not as approved wording for any market.

Swipe horizontally to view all columns →

Write claims from the evidence you have, not the evidence you hope to get, and check listings, ads and influencer briefs as well as the pack.

Section takeaway: ingredient research supports choosing niacinamide. A product claim needs evidence adequate for the specific wording and market; finished-product testing often provides the clearest support. Keep wording at the level of appearance and feel unless a qualified adviser confirms otherwise for your market.

Sample Comparison Sheet and Inquiry Checklist

Record every sample round on the same sheet, and note what you cannot judge yet, because those gaps decide what the next round must deliver.

What to send the manufacturer with your first inquiry

• Target markets, in order of launch.
• Target consumer and the main skin concern, written in cosmetic terms.
• Format (serum, cream or rinse-off) and any second format planned for the same range.
• Desired appearance, texture and finish, with a reference product if you have one.
• Intended claims for pack and listings, and words you have ruled out.
• Every co-active you would like in the same product.
• Packaging direction, including any material or decoration constraints.
• Fragrance-free or fragranced, and any free-from requirements.
• The documents you expect with each sample round (specification, lot COA, stated basis of the level).
• The finished-product tests you expect to need, so the manufacturer can scope them.
• Estimated first order quantity and target launch window, stated as your plan rather than a request for a promise.

Fictional sample record

The entries below are invented to show the format. They are not results from any real sample.

Swipe horizontally to view all columns →

At each round, make one of three decisions and write it down:

• Accept the round for the next stage, listing exactly which evidence is still open.
• Revise, with specific changes, such as "reduce tack" or "move to pump".
• Stop or rethink, if the format cannot meet the claim or the feel target.

A sample can pass on feel and still be far from launch-ready; the "cannot judge yet" column keeps that visible.

Section takeaway: send the same complete brief to every manufacturer, record each round on one sheet, and keep a visible list of what is still unproven.

Working With GZ Cosmetics Lab on a Niacinamide Project

If a serum is the direction you are considering, our niacinamide serum catalogue listing can be a discussion reference for your brief. A listing is not proof that a particular formula, test package or market claim is available for your project. Ask us to confirm the proposed composition, documents, sample feasibility and destination-market wording for your actual brief.

When you send a project inquiry, include the brief fields above and the documents and tests you expect. We will confirm what can be supplied for your project and what still needs to be scoped, including commercial terms and any proposed product claim.

Overall Takeaway

Niacinamide is easy to add and easy to overclaim. Work in this order: brief the outcome and claims instead of a percentage; choose the format by contact time and claim ambition; request lot-level raw-material documents and plan finished-product tests on the real formula and pack; and keep ingredient research, related-formula data and final-product data apart when writing claims.

Frequently Asked Questions

What niacinamide percentage should we ask for? Ask the manufacturer to propose a level for your formula, state whether it refers to pure niacinamide or a supplied blend, and explain the reasoning. Published studies tested specific formulas, so their percentages are background, not a target for every product.

Can a niacinamide cleanser make the same claims as a serum? Not by default. A rinse-off product contacts skin briefly, and leave-on study results do not transfer to it. A cleanser needs its own evidence for any benefit beyond cleansing and skin feel.

Is a COA enough to prove the raw material is suitable? A COA reports whether a specific lot met the supplier's specification. You also need the specification itself, the grade name and the basis of the stated level. Suitability in your product then needs appropriate finished-product checks.

Why does residual nicotinic acid come up in raw-material discussions? Some suppliers include a residual nicotinic-acid limit in a niacinamide grade's specification. Ask which limit applies to the proposed grade and what formulation conditions the supplier recommends; do not transfer a different supplier's figure to your product.

Can we say our niacinamide product reduces dark spots? In the US, wording that implies treating a skin condition or changing skin function can make the product a drug. Appearance wording such as "helps skin look more even-toned" is a possible cosmetic route, while the EU requires evidence adequate for the specific product and claim. Review the final wording for each market with a qualified adviser.

Sources

• U.S. Food and Drug Administration, "Cosmetics Labeling Claims": https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetics-labeling-claims
• Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32013R0655
• Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. International Journal of Cosmetic Science, 2004;26(5):231–238: https://pubmed.ncbi.nlm.nih.gov/18492135/